Neuromyelitis optica;Neuromyelitis optica

Nervenarzt

Volumn 78, Issue 12, 2007, Pages 1365-1377

  Jarius, S ^a   Wildemann, B ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Aquaporin 4; Demyelination; Humoral immune response; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

IMMUNOGLOBULIN G; RITUXIMAB;

AUTOIMMUNE DISEASE; BRAIN DAMAGE; DEMYELINATING DISEASE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; LABORATORY DIAGNOSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE; RECURRENT DISEASE; REVIEW; STATISTICAL SIGNIFICANCE;

GERMANY; HUMANS; NEUROMYELITIS OPTICA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 36649017940     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-007-2262-8     Document Type: Review

References (99)

1. Aguilera AJ, Carlow TJ, Smith KJ et al. (1985) Lymphocytaplasmapheresis in Devic's syndrome. Transfusion 25: 54-56
2. Amiry-Moghaddam M, Ottersen OP (2003) The molecular basis of water transport in the brain. Nat Rev Neurosci 4: 991-1001
3. + clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of alpha-syntrophin-null mice. Proc Natl Acad Sci U S A 100: 13615-13620
4. Amiry-Moghaddam M, Frydenlund DS, Ottersen OP (2004) Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 129: 999-1010
5. Auguste KI, Jin S, Uchida K et al. (2007) Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury. FASEB J 21: 108-116
6. Bakker J, Metz L (2004) Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci 31: 265-267
7. Benedetti B, Valsasina P, Judica E et al. (2006) Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI. Neurology 67: 161-163
8. Bergamaschi R (2003) Glatiramer acetate treatment in Devic's neuromyelitis optica. Brain 126: 1E; author reply 1E-a
9. Bergamaschi R, Uggetti C, Tonietti S et al. (2003) A case of relapsing neuromyelitis optica treated with glatiramer acetate. J Neurol 250: 359-361
10. Bergamaschi R, Tonietti S, Franciotta D et al. (2004) Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler 10: 2-4
11. Cabrera-Gomez JA, Quevedo-Sotolongo L, Gonzalez-Quevedo A et al. (2007) Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler 13: 186-192
12. Cloys DE, Netsky MG (1970) Neuromyelitis optica. In: Vinken PJ, Bruyn GW (eds) Handbook of Clinical Neurology. North Holland Publishing Company, Amsterdam, pp 426-436
13. Compston A (2004) 'The marvellous harmony of the nervous parts': the origins of multiple sclerosis. Clin Med 4: 346-354
14. Correale J, Fiol M (2004) Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 63: 2363-2370
15. Cree BA, Lamb S, Morgan K et al. (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270-1272
16. Seze J de, Stojkovic T, Ferriby D et al. (2002) Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197: 57-61
17. Devic E (1894) Myélite subaiguë compliquée de névrite optique. Bull Méd 8: 1033-1034
18. Devic E (1895) Myelite aigue dorse-lombaire de neurite optique, autopsie. Congress Francais Medicine, Lyon, pp 434-439
19. Duda PW, Schmied MC, Cook SL et al. (2000) Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest 105: 967-976
20. Falcini F, Trapani S, Ricci L et al. (2006) Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment. Rheumatology (Oxford) 45: 913-915
21. Fidler JM, DeJoy SQ, Gibbons JJ Jr. (1986) Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function. J Immunol 137: 727-732
22. Fidler JM, DeJoy SQ, Smith FR 3rd et al. (1986) Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice. J Immunol 136: 2747-2754
23. Filippi M, Rocca MA (2004) MR imaging of Devic's neuromyelitis optica. Neurol Sci (Suppl 4) 25: S371-S373
24. Fukazawa T, Kikuchi S, Miyagishi R et al. (2006) HLA-dPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301. Mult Scler 12: 19-23
25. Furman CS, Gorelick-Feldman DA, Davidson KG et al. (2003) Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A 100: 13609-13614
26. Gartzen K, Limmroth V, Putzki N (2007) Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. Eur J Neurol 14: e12-e13
27. Ghezzi A, Bergamaschi R, Martinelli V et al. (2004) Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 251: 47-52
28. Goehler LE, Erisir A, Gaykema RP (2006) Neural-immune interface in the rat area postrema. Neuroscience 140: 1415-1434
29. Green AJ, Hauser S, Cree B (2007) Funduscopic and optical coherence tomography findings in meuromyelitis optica compared to multiple sclerosis. Neurology 68: A355
30. Hengstman GJ, Wesseling P, Frenken CW et al. (2007) Neuromyelitis optica with clinical and histopathological involvement of the brain. Mult Scler 13: 679-682
31. Hiroaki Y, Tani K, Kamegawa A et al. (2006) Implications of the aquaporin-4 structure on array formation and cell adhesion. J Mol Biol 355: 628-639
32. Ishizu T, Osoegawa M, Mei FJ et al. (2005) Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128: 988-1002
33. Ito H, Yamasaki K, Kawano Y et al. (1998) HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 52: 179-182
34. Jacobi C, Stingele K, Kretz R et al. (2006) Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus. Lupus 15: 107-109
35. Jarius S, Franciotta D, Bergamaschi R et al. (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68: 1076-1077
36. Jung JS, Bhat RV, Preston GM et al. (1994) Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci U S A 91: 13052-13056
37. Keegan M, Pineda AA, McClelland RL et al. (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58: 143-146
38. Kira J, Kanai T, Nishimura Y et al. (1996) Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40: 569-574
39. Kobayashi H, Minami S, Itoh S et al. (2001) Aquaporin subtypes in rat cerebral microvessels. Neurosci Lett 297: 163-166
40. Lalive PH, Menge T, Barman I et al. (2006) Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 67: 176-177
41. Lee KH, Hashimoto SA, Hooge JP et al. (1991) Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 41: 657-660
42. Lennon VA, Wingerchuk DM, Kryzer TJ et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112
43. Lennon VA, Kryzer TJ, Pittock SJ et al. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477
44. Lin F, Yu C, Jiang T et al. (2006) Discriminative analysis of relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis based on two-dimensional histogram from diffusion tensor imaging. Neuroimage 31: 543-549
45. Lu M, Lee MD, Smith BL et al. (1996) The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain. Proc Natl Acad Sci U S A 93: 10908-10912
46. Lucchinetti CF, Mandler RN, McGavern D et al. (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125: 1450-1461
47. Lucchinetti CF, Bruck W, Lassmann H (2004) Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56: 308
48. Lycklama G, Thompson A, Filippi M et al. (2000) Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2: 555-562
49. Mandler RN, Davis LE, Jeffery DR et al. (1993) Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34: 162-168
50. Mandler RN, Ahmed W, Dencoff JE (1998) Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51: 1219-1220
51. Mandler RN, Dencoff JD, Midani F et al. (2001) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain 124: 493-498
52. Manley GT, Fujimura M, Ma T et al. (2000) Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6: 159-163
53. Matsuoka T, Matsushita T, Kawano Y et al. (2007) Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130: 1206-1223
54. Melamud L, Madalena L, Facio ML et al. (2006) Cerebrospinal fluid findings in Devic's neuromyelitis optica. Mult Scler 12: P246
55. Misu T, Fujihara K, Kakita A et al. (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130: 1224-1234
56. Nakashima I, Fujihara K, Miyazawa I et al. (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77: 1073-1075
57. Narikawa K, Misu T, Fujihara K et al. (2004) CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol 149: 182-186
58. Neely JD, Amiry-Moghaddam M, Ottersen OP et al. (2001) Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc Natl Acad Sci U S A 98: 14108-14113
59. Nielsen S, Nagelhus EA, Amiry-Moghaddam M et al. (1997) Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17: 171-180
60. Nozaki I, Hamaguchi T, Komai K et al. (2006) Fulminant Devic disease successfully treated by lymphocytapheresis. J Neurol Neurosurg Psychiatry 77: 1094-1095
61. O'Riordan JI, Gallagher HL, Thompson AJ et al. (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60: 382-387
62. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M et al. (2002) Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 73: 429-435
63. Papeix C, Vidal JS, Seze J de et al. (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13: 256-259
64. Paul F, Jarius S, Aktas O et al. (2007) Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 4: e133
65. Petravic D, Habek M, Supe S et al. (2006) Recurrent optic neuromyelitis with endocrinopathies: a new syndrome or just a coincidence? Mult Scler 12: 670-673
66. Pittock SJ, Lennon VA, Krecke K et al. (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63: 390-396
67. Pittock SJ, Lucchinetti CF (2006) Inflammatory transverse myelitis: evolving concepts. Curr Opin Neurol 19: 362-368
68. Pittock SJ, Weinshenker BG, Lucchinetti CF et al. (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63: 964-968
69. Poppe AY, Lapierre Y, Melancon D et al. (2005) Neuromyelitis optica with hypothalamic involvement. Mult Scler 11: 617-621
70. Prineas JW, McDonald WI (1997) Demyelinating diseases. In: Graham DI, Lantos PL (eds) Greenfield's Neuropathology. 6th edn. Arnold, London, pp 813-896
71. Roemer SF, Parisi JE, Lennon VA et al. (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130: 1194-1205
72. Saida T, Tashiro K, Itoyama Y et al. (2005) Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 64: 621-630
73. Satoh J, Yukitake M, Kurohara K et al. (2003) Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis. J Neurol Sci 212: 11-20
74. Schulz M, Engelhardt B (2005) The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal Fluid Res 2: 8
75. Simard M, Nedergaard M (2004) The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129: 877-896
76. Sinclair C, Kirk J, Herron B et al. (2007) Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol (Berl) 113: 187-194
77. Sui H, Han BG, Lee JK et al. (2001) Structural basis of water-specific transport through the AQP1 water channel. Nature 414: 872-878
78. Takahashi T, Fujihara K, Nakashima I et al. (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130: 1235-1243
79. Tartaglino LM, Friedman DP, Flanders AE et al. (1995) Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195: 725-732
80. Transverse_Myelitis_Consortium_Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59: 499-505
81. Vernant JC, Cabre P, Smadja D et al. (1997) Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 48: 58-64
82. Warabi Y, Matsumoto Y, Hayashi H (2007) Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 252: 57-61
83. Watanabe S, Misu T, Miyazawa I et al. (2007) Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler
84. Weinshenker B, Pittock SJ, Seze J de (2006) The relationship between neuromyelitis optica and systemic auto-immune disease. Mult Scler 12: O79
85. Weinshenker BG, O'Brien PC, Petterson TM et al. (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46: 878-886
86. Weinshenker BG, Wingerchuk DM, Nakashima I et al. (2006) OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5: 110-111
87. Weinshenker BG, Wingerchuk DM, Vukusic S et al. (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59: 566-569
88. Weinstock-Guttman B, Ramanathan M, Lincoff N et al. (2006) Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 63: 957-963
89. Wen H, Nagelhus EA, Amiry-Moghaddam M et al. (1999) Ontogeny of water transport in rat brain: postnatal expression of the aquaporin-4 water channel. Eur J Neurosci 11: 935-945
90. Wingerchuk DM, Hogancamp WF, O'Brien PC et al. (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114
91. Wingerchuk DM, Lennon VA, Pittock SJ et al. (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489
92. Wingerchuk DM, Pittock SJ, Lucchinetti CF et al. (2007) A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 68: 603-605
93. Yang B, Ma T, Verkman AS (1995) cDNA cloning, gene organization, and chromosomal localization of a human mercurial insensitive water channel. Evidence for distinct transcriptional units. J Biol Chem 270: 22907-22913
94. Yong VW (2002) Differential mechanisms of action of interferon-beta and glatiramer aetate in MS. Neurology 59: 802-808
95. Yu CS, Lin FC, Li KC et al. (2006) Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am J Neuroradiol 27: 1009-1015
96. Yu CS, Zhu CZ, Li KC et al. (2007) Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum. Radiology 244: 249-256
97. Zaffaroni M (2004) Cerebrospinal fluid findings in Devic's neuromyelitis optica. Neurol Sci [Suppl 4] 25: S368-S370
98. Zhang ET, Inman CB, Weller RO (1990) Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. J Anat 170: 111-123
99. Zivkovic SA, Heyman R, Pless M (2003) Subacute rhombencephalitis optica responsive to intravenous immunoglobulins. Eur J Neurol 10: 83-86